Drugs / AS900672-Enriched
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00553514 | Dec 2007 → Mar 2009 | female infertility | Merck KGaA, Darmstadt, Germany | Terminated | No outcome recorded |
| Phase 2 | NCT00505752 | Jan 2007 → Sep 2008 | infertility disorder | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS900672-Enriched | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00553514 ↗ |
| Modality | Protein / enzyme biologic | “Single injection of AS900672-Enriched (hyperglycosylated r-hFSH), 100 mcg will be administered subcutaneously on S1.” NCT00505752 ↗ |
| Route | Subcutaneous | “Single injection of AS900672-Enriched (hyperglycosylated r-hFSH), 100 mcg will be administered subcutaneously on S1.” NCT00505752 ↗ |